{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-carpal-tunnel","title":"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surrounding tendons or tissues. Over time the pressure can lead to nerve irritation, reduced blood flow to the nerve, and changes in nerve conduction.\n\nIf the swelling persists, the protective myelin sheath around the nerve fibers can thin. This slows or blocks signals traveling to and from the fingers and hand. In longer cases some axons may degenerate, which means the nerve itself loses parts of its structure.\n\nThe condition sits at the intersection of mechanical pressure and biological repair. When tissue breakdown outpaces the body's ability to clear inflammation and rebuild nerve support, symptoms such as numbness, tingling, and weakness continue.\n\n## Why PT-141 might help you\n\n1. You are reading about carpal tunnel syndrome — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system. This pathway is best studied for sexual arousal. If carpal tunnel symptoms include a central nervous system component such as altered pain processing or reduced nerve signaling efficiency, the same receptors might intersect with repair signals in theory. No direct if-then chain from arousal to median-nerve regeneration has been mapped in published work.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- PT-141 → sexual / CNS arousal\n\nThe discussion stays limited to one compound because only PT-141 appears in scope. Any synergy would require additional compounds aimed at inflammation or local tissue repair, which are outside this review.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair. (tier: mechanistic — absence of data)\n\nAll published clinical work on PT-141 examines its effects on hypoactive sexual desire disorder in women. Phase 3 trials measured sexually satisfying events and distress scores versus placebo. Those trials did not assess nerve function, inflammation markers, or hand symptoms. (tier: human — sexual indication only)\n\nPreclinical data on melanocortin agonists show receptor activity in brain regions tied to arousal. No studies extend those findings to peripheral nerve compression models. (tier: preclinical — unrelated endpoint)\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual desire through central nervous system pathways. Reviews note its approval for one specific indication and list common side effects such as nausea and flushing. No scientist has published on carpal tunnel applications. (tier: mechanistic)\n\n## What people say on Reddit\n\nReddit threads mention PT-141 only in the context of sexual effects or side effects such as flushing. Separate threads discuss carpal tunnel-like symptoms as a side effect of growth-hormone-related peptides, not as a condition improved by PT-141. No user reports describe PT-141 relieving carpal tunnel symptoms. (tier: anecdotal)\n\n## What people say on X\n\nPublic posts on X contain no documented discussions linking PT-141 to carpal tunnel syndrome. Searches return only general peptide or sexual-health mentions. (tier: anecdotal — absence of data)\n\n## What we do not know\n\nIt is unknown whether PT-141 crosses into peripheral nerve repair pathways relevant to carpal tunnel. No dose-response data, duration studies, or safety signals exist for this use. Long-term effects on nerve compression remain unexamined.\n\n## Safety and limits\n\nPT-141 carries an FDA-approved label for hypoactive sexual desire disorder with documented side effects including nausea, flushing, and blood-pressure changes. Any off-label exploration carries those same risks plus unknown interactions with nerve-compression physiology. Evidence grading shows zero human or animal support for carpal tunnel applications at this time.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-carpal-tunnel/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No published human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of supporting data for the claimed use.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 trials of PT-141 measured sexually satisfying events and distress scores versus placebo but did not assess nerve function or hand symptoms.","section":"What the evidence actually shows","tier":"human","source_ids":["s2","s1"],"source_status":"sourced","why_material":"Clarifies the actual endpoints studied in existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 is a melanocortin-4 receptor agonist approved for hypoactive sexual desire disorder.","section":"What scientists say","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the known approved use and mechanism.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users discuss PT-141 side effects and separately mention carpal tunnel symptoms from other peptides, with no reports of PT-141 improving carpal tunnel.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents the anecdotal record as empty for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide is a melanocortin receptor agonist and has been recently approved by the FDA to treat HSDD.","summary":"Clinical review of PT-141 trials; no mention of nerve or carpal tunnel outcomes.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"c6ce19998a4430c1dc0d9f0b78c41bda433ec852d53da268469f68ac9b584746"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Phase 3 trials showed improvements in sexually satisfying events.","summary":"Confirms trial endpoints limited to sexual function.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"ok","quote_status":"unverified","prev":"c6ce19998a4430c1dc0d9f0b78c41bda433ec852d53da268469f68ac9b584746","hash":"cbbc8503d40995eaf75d088d1453ffa078ab19d1e9ad4275d8e78eac34b36187"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.","summary":"Official indication and mechanism summary.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"http_403","quote_status":"unverified","prev":"cbbc8503d40995eaf75d088d1453ffa078ab19d1e9ad4275d8e78eac34b36187","hash":"348593a711500a13ca531e902a2c3d76e27240097eedc010ba11951aa4ee9e17"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/ParamountPeptide/comments/1udgtvm/whats_the_weirdest_side_effect_you_had_that/","title":"Whats the weirdest side effect you had that turned out to be ...","quote":"For some people its the carpal tunnel feeling from GH peptides. For others its the flushing on PT-141","summary":"Illustrates separate discussion of carpal tunnel and PT-141 side effects with no therapeutic link reported.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"ok","quote_status":"unverified","prev":"348593a711500a13ca531e902a2c3d76e27240097eedc010ba11951aa4ee9e17","hash":"f886f65d958efa7831f4bae4cbb94aaf0023947c05b25030a50ff8d52220342a"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:21:01.272Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surrounding tendons or tissues. Over time the pressure can lead to nerve irritation, reduced blood flow to the nerve, and changes in nerve conduction.\n\nIf the swelling persists, the protective myelin sheath around the nerve fibers can thin. This slows or blocks signals traveling to and from the fingers and hand. In longer cases some axons may degenerate, which means the nerve itself loses parts of its structure.\n\nThe condition sits at the intersection of mechanical pressure and biological repair. When tissue breakdown outpaces the body's ability to clear inflammation and rebuild nerve support, symptoms such as numbness, tingling, and weakness continue.\n\n## Why PT-141 might help you\n\n1. You are reading about carpal tunnel syndrome — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system. This pathway is best studied for sexual arousal. If carpal tunnel symptoms include a central nervous system component such as altered pain processing or reduced nerve signaling efficiency, the same receptors might intersect with repair signals in theory. No direct if-then chain from arousal to median-nerve regeneration has been mapped in published work.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- PT-141 → sexual / CNS arousal\n\nThe discussion stays limited to one compound because only PT-141 appears in scope. Any synergy would require additional compounds aimed at inflammation or local tissue repair, which are outside this review.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair. (tier: mechanistic — absence of data)\n\nAll published clinical work on PT-141 examines its effects on hypoactive sexual desire disorder in women. Phase 3 trials measured sexually satisfying events and distress scores versus placebo. Those trials did not assess nerve function, inflammation markers, or hand symptoms. (tier: human — sexual indication only)\n\nPreclinical data on melanocortin agonists show receptor activity in brain regions tied to arousal. No studies extend those findings to peripheral nerve compression models. (tier: preclinical — unrelated endpoint)\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual desire through central nervous system pathways. Reviews note its approval for one specific indication and list common side effects such as nausea and flushing. No scientist has published on carpal tunnel applications. (tier: mechanistic)\n\n## What people say on Reddit\n\nReddit threads mention PT-141 only in the context of sexual effects or side effects such as flushing. Separate threads discuss carpal tunnel-like symptoms as a side effect of growth-hormone-related peptides, not as a condition improved by PT-141. No user reports describe PT-141 relieving carpal tunnel symptoms. (tier: anecdotal)\n\n## What people say on X\n\nPublic posts on X contain no documented discussions linking PT-141 to carpal tunnel syndrome. Searches return only general peptide or sexual-health mentions. (tier: anecdotal — absence of data)\n\n## What we do not know\n\nIt is unknown whether PT-141 crosses into peripheral nerve repair pathways relevant to carpal tunnel. No dose-response data, duration studies, or safety signals exist for this use. Long-term effects on nerve compression remain unexamined.\n\n## Safety and limits\n\nPT-141 carries an FDA-approved label for hypoactive sexual desire disorder with documented side effects including nausea, flushing, and blood-pressure changes. Any off-label exploration carries those same risks plus unknown interactions with nerve-compression physiology. Evidence grading shows zero human or animal support for carpal tunnel applications at this time.","claims":[{"id":"c1","text":"No published human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of supporting data for the claimed use.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 trials of PT-141 measured sexually satisfying events and distress scores versus placebo but did not assess nerve function or hand symptoms.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the actual endpoints studied in existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 is a melanocortin-4 receptor agonist approved for hypoactive sexual desire disorder.","section":"What scientists say","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the known approved use and mechanism.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users discuss PT-141 side effects and separately mention carpal tunnel symptoms from other peptides, with no reports of PT-141 improving carpal tunnel.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents the anecdotal record as empty for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide is a melanocortin receptor agonist and has been recently approved by the FDA to treat HSDD.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Phase 3 trials showed improvements in sexually satisfying events.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/ParamountPeptide/comments/1udgtvm/whats_the_weirdest_side_effect_you_had_that/","title":"Whats the weirdest side effect you had that turned out to be ...","quote":"For some people its the carpal tunnel feeling from GH peptides. For others its the flushing on PT-141","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":12029,"tokens_out":2744,"cost":0.02189625,"prev_hash":"genesis","hash":"37f21012e87ac5a8020cf1c976815f11ff4a1d3f558d8ec56c7a640e557815fb"}],"provenance":[{"ts":"2026-06-30T01:21:01.272Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Carpal Tunnel\nSlug: pt-141-carpal-tunnel\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Carpal tunnel syndrome\",\"condition_key\":\"carpal-tunnel\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Carpal tunnel syndrome\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have Carpal tunnel syndrome\",\"Why PT-141 might help you\",\"How th","response":"{\"slug\":\"pt-141-carpal-tunnel\",\"title\":\"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review\",\"body\":\"## What's breaking down if you have Carpal tunnel syndrome\\n\\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surrounding tendons or tissues. Over time the pressure can lead to nerve irritation, reduced blood flow to the nerve, and changes in nerve conduction.\\n\\nIf the swelling persists, the protective myelin sheath around the nerve fibers can thin. This slows or blocks signals traveling to and from the fingers and hand. In longer cases some axons may degenerate, which means the nerve itself loses parts of its structure.\\n\\nThe condition sits at the intersection of mechanical pressure and biological repair. When tissue breakdown outpaces the body's ability to clear inflammation and rebuild nerve support, symptoms such as numbness, tingling, and weakness continue.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about carpal tunnel syndrome — what breaks down matters before any compound name.\\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts on melanocortin receptors in the central nervous system. This pathway is best studied for sexual arousal. If carpal tunnel symptoms include a central nervous system component such as altered pain processing or reduced nerve signaling efficiency, the same receptors might intersect with repair signals in theory. No direct if-then chain from arousal to median-nerve regeneration has been mapped in published work.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- PT-141 → sexual / CNS arousal\\n\\nThe discussion stays limited to one compound because only PT-141","tokens_in":12029,"tokens_out":2744,"cost":0,"prev":"genesis","hash":"10c05de3848eeeb7be009b4d6e6f847d38699a22cd4f795abe6f846bfe0843b8"},{"ts":"2026-07-17T02:41:04.353Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-carpal-tunnel","response":"25 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"10c05de3848eeeb7be009b4d6e6f847d38699a22cd4f795abe6f846bfe0843b8","hash":"e6860be943e1a578f2943c0fde4a78716d519eb5548a98af00bc45d9bc43b3f0"}],"energy":{"passes":2,"tokens_in":12029,"tokens_out":2744,"tokens_total":14773,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e6860be943e1a578f2943c0fde4a78716d519eb5548a98af00bc45d9bc43b3f0"},"posted_at":"2026-06-29T21:32:51.525Z","created_at":"2026-06-29T21:32:51.525Z","updated_at":"2026-07-17T02:41:04.353Z","machine":{"shape":"article.machine/v1","slug":"pt-141-carpal-tunnel","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-carpal-tunnel","json":"https://miscsubjects.com/api/articles/pt-141-carpal-tunnel","bundle":"https://miscsubjects.com/api/articles/pt-141-carpal-tunnel/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-carpal-tunnel/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-carpal-tunnel","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-carpal-tunnel\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-carpal-tunnel\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-carpal-tunnel/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-carpal-tunnel\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-carpal-tunnel | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-carpal-tunnel","json":"/api/articles/pt-141-carpal-tunnel","markdown":"/api/articles/pt-141-carpal-tunnel/bundle?format=markdown","skill":"/api/articles/pt-141-carpal-tunnel/skill","topology":"/api/articles/pt-141-carpal-tunnel/topology","versions":"/api/articles/pt-141-carpal-tunnel/revisions","invocations":"/api/articles/pt-141-carpal-tunnel/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-carpal-tunnel","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"d9d639c3d71583cc512572a6233274e04b6d624ac2c29462fc9675f059ac8ac5","object":{"object_type":"article-object","identity":{"id":"article:pt-141-carpal-tunnel","slug":"pt-141-carpal-tunnel","title":"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-carpal-tunnel","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-carpal-tunnel/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-carpal-tunnel\ndescription: Apply the PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-carpal-tunnel). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-carpal-tunnel.\n- Read claims and relationships at /api/articles/pt-141-carpal-tunnel/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Carpal tunnel syndrome Carpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surroundin\n\n## Representations\n\n- Human: /a/pt-141-carpal-tunnel\n- JSON: /api/articles/pt-141-carpal-tunnel\n- Relationships: /api/articles/pt-141-carpal-tunnel/topology\n- History: /api/articles/pt-141-carpal-tunnel/revisions\n"},"json":{"route":"/api/articles/pt-141-carpal-tunnel","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-carpal-tunnel/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","carpal","tunnel"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-carpal-tunnel/invocations?status=success","failure_events":"/api/articles/pt-141-carpal-tunnel/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-carpal-tunnel","title":"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surrounding tendons or tissues. Over time the pressure can lead to nerve irritation, reduced blood flow to the nerve, and changes in nerve conduction.\n\nIf the swelling persists, the protective myelin sheath around the nerve fibers can thin. This slows or blocks signals traveling to and from the fingers and hand. In longer cases some axons may degenerate, which means the nerve itself loses parts of its structure.\n\nThe condition sits at the intersection of mechanical pressure and biological repair. When tissue breakdown outpaces the body's ability to clear inflammation and rebuild nerve support, symptoms such as numbness, tingling, and weakness continue.\n\n## Why PT-141 might help you\n\n1. You are reading about carpal tunnel syndrome — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system. This pathway is best studied for sexual arousal. If carpal tunnel symptoms include a central nervous system component such as altered pain processing or reduced nerve signaling efficiency, the same receptors might intersect with repair signals in theory. No direct if-then chain from arousal to median-nerve regeneration has been mapped in published work.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- PT-141 → sexual / CNS arousal\n\nThe discussion stays limited to one compound because only PT-141 appears in scope. Any synergy would require additional compounds aimed at inflammation or local tissue repair, which are outside this review.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair. (tier: mechanistic — absence of data)\n\nAll published clinical work on PT-141 examines its effects on hypoactive sexual desire disorder in women. Phase 3 trials measured sexually satisfying events and distress scores versus placebo. Those trials did not assess nerve function, inflammation markers, or hand symptoms. (tier: human — sexual indication only)\n\nPreclinical data on melanocortin agonists show receptor activity in brain regions tied to arousal. No studies extend those findings to peripheral nerve compression models. (tier: preclinical — unrelated endpoint)\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual desire through central nervous system pathways. Reviews note its approval for one specific indication and list common side effects such as nausea and flushing. No scientist has published on carpal tunnel applications. (tier: mechanistic)\n\n## What people say on Reddit\n\nReddit threads mention PT-141 only in the context of sexual effects or side effects such as flushing. Separate threads discuss carpal tunnel-like symptoms as a side effect of growth-hormone-related peptides, not as a condition improved by PT-141. No user reports describe PT-141 relieving carpal tunnel symptoms. (tier: anecdotal)\n\n## What people say on X\n\nPublic posts on X contain no documented discussions linking PT-141 to carpal tunnel syndrome. Searches return only general peptide or sexual-health mentions. (tier: anecdotal — absence of data)\n\n## What we do not know\n\nIt is unknown whether PT-141 crosses into peripheral nerve repair pathways relevant to carpal tunnel. No dose-response data, duration studies, or safety signals exist for this use. Long-term effects on nerve compression remain unexamined.\n\n## Safety and limits\n\nPT-141 carries an FDA-approved label for hypoactive sexual desire disorder with documented side effects including nausea, flushing, and blood-pressure changes. Any off-label exploration carries those same risks plus unknown interactions with nerve-compression physiology. Evidence grading shows zero human or animal support for carpal tunnel applications at this time.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-carpal-tunnel/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No published human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of supporting data for the claimed use.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 trials of PT-141 measured sexually satisfying events and distress scores versus placebo but did not assess nerve function or hand symptoms.","section":"What the evidence actually shows","tier":"human","source_ids":["s2","s1"],"source_status":"sourced","why_material":"Clarifies the actual endpoints studied in existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 is a melanocortin-4 receptor agonist approved for hypoactive sexual desire disorder.","section":"What scientists say","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the known approved use and mechanism.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users discuss PT-141 side effects and separately mention carpal tunnel symptoms from other peptides, with no reports of PT-141 improving carpal tunnel.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents the anecdotal record as empty for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide is a melanocortin receptor agonist and has been recently approved by the FDA to treat HSDD.","summary":"Clinical review of PT-141 trials; no mention of nerve or carpal tunnel outcomes.","claim_ids":["c1","c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"ok","quote_status":"verified","prev":"genesis","hash":"c6ce19998a4430c1dc0d9f0b78c41bda433ec852d53da268469f68ac9b584746"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Phase 3 trials showed improvements in sexually satisfying events.","summary":"Confirms trial endpoints limited to sexual function.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"ok","quote_status":"unverified","prev":"c6ce19998a4430c1dc0d9f0b78c41bda433ec852d53da268469f68ac9b584746","hash":"cbbc8503d40995eaf75d088d1453ffa078ab19d1e9ad4275d8e78eac34b36187"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.","summary":"Official indication and mechanism summary.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"http_403","quote_status":"unverified","prev":"cbbc8503d40995eaf75d088d1453ffa078ab19d1e9ad4275d8e78eac34b36187","hash":"348593a711500a13ca531e902a2c3d76e27240097eedc010ba11951aa4ee9e17"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/ParamountPeptide/comments/1udgtvm/whats_the_weirdest_side_effect_you_had_that/","title":"Whats the weirdest side effect you had that turned out to be ...","quote":"For some people its the carpal tunnel feeling from GH peptides. For others its the flushing on PT-141","summary":"Illustrates separate discussion of carpal tunnel and PT-141 side effects with no therapeutic link reported.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:21:00.819Z","link_status":"ok","quote_status":"unverified","prev":"348593a711500a13ca531e902a2c3d76e27240097eedc010ba11951aa4ee9e17","hash":"f886f65d958efa7831f4bae4cbb94aaf0023947c05b25030a50ff8d52220342a"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:21:01.272Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Carpal tunnel syndrome\n\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surrounding tendons or tissues. Over time the pressure can lead to nerve irritation, reduced blood flow to the nerve, and changes in nerve conduction.\n\nIf the swelling persists, the protective myelin sheath around the nerve fibers can thin. This slows or blocks signals traveling to and from the fingers and hand. In longer cases some axons may degenerate, which means the nerve itself loses parts of its structure.\n\nThe condition sits at the intersection of mechanical pressure and biological repair. When tissue breakdown outpaces the body's ability to clear inflammation and rebuild nerve support, symptoms such as numbness, tingling, and weakness continue.\n\n## Why PT-141 might help you\n\n1. You are reading about carpal tunnel syndrome — what breaks down matters before any compound name.\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts on melanocortin receptors in the central nervous system. This pathway is best studied for sexual arousal. If carpal tunnel symptoms include a central nervous system component such as altered pain processing or reduced nerve signaling efficiency, the same receptors might intersect with repair signals in theory. No direct if-then chain from arousal to median-nerve regeneration has been mapped in published work.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- PT-141 → sexual / CNS arousal\n\nThe discussion stays limited to one compound because only PT-141 appears in scope. Any synergy would require additional compounds aimed at inflammation or local tissue repair, which are outside this review.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair. (tier: mechanistic — absence of data)\n\nAll published clinical work on PT-141 examines its effects on hypoactive sexual desire disorder in women. Phase 3 trials measured sexually satisfying events and distress scores versus placebo. Those trials did not assess nerve function, inflammation markers, or hand symptoms. (tier: human — sexual indication only)\n\nPreclinical data on melanocortin agonists show receptor activity in brain regions tied to arousal. No studies extend those findings to peripheral nerve compression models. (tier: preclinical — unrelated endpoint)\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual desire through central nervous system pathways. Reviews note its approval for one specific indication and list common side effects such as nausea and flushing. No scientist has published on carpal tunnel applications. (tier: mechanistic)\n\n## What people say on Reddit\n\nReddit threads mention PT-141 only in the context of sexual effects or side effects such as flushing. Separate threads discuss carpal tunnel-like symptoms as a side effect of growth-hormone-related peptides, not as a condition improved by PT-141. No user reports describe PT-141 relieving carpal tunnel symptoms. (tier: anecdotal)\n\n## What people say on X\n\nPublic posts on X contain no documented discussions linking PT-141 to carpal tunnel syndrome. Searches return only general peptide or sexual-health mentions. (tier: anecdotal — absence of data)\n\n## What we do not know\n\nIt is unknown whether PT-141 crosses into peripheral nerve repair pathways relevant to carpal tunnel. No dose-response data, duration studies, or safety signals exist for this use. Long-term effects on nerve compression remain unexamined.\n\n## Safety and limits\n\nPT-141 carries an FDA-approved label for hypoactive sexual desire disorder with documented side effects including nausea, flushing, and blood-pressure changes. Any off-label exploration carries those same risks plus unknown interactions with nerve-compression physiology. Evidence grading shows zero human or animal support for carpal tunnel applications at this time.","claims":[{"id":"c1","text":"No published human trials, rat studies, or mechanistic papers link PT-141 to carpal tunnel syndrome or median-nerve repair.","section":"What the evidence actually shows","tier":"mechanistic","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes complete absence of supporting data for the claimed use.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"Phase 3 trials of PT-141 measured sexually satisfying events and distress scores versus placebo but did not assess nerve function or hand symptoms.","section":"What the evidence actually shows","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the actual endpoints studied in existing human data.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"PT-141 is a melanocortin-4 receptor agonist approved for hypoactive sexual desire disorder.","section":"What scientists say","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Grounds the known approved use and mechanism.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users discuss PT-141 side effects and separately mention carpal tunnel symptoms from other peptides, with no reports of PT-141 improving carpal tunnel.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents the anecdotal record as empty for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:21:00.906Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"review","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Bremelanotide is a melanocortin receptor agonist and has been recently approved by the FDA to treat HSDD.","link_status":"ok","quote_status":"verified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8788464/","title":"Bremelanotide for Treatment of Female Hypoactive Sexual Desire Disorder","quote":"Phase 3 trials showed improvements in sexually satisfying events.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route)","quote":"Bremelanotide injection is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women.","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/ParamountPeptide/comments/1udgtvm/whats_the_weirdest_side_effect_you_had_that/","title":"Whats the weirdest side effect you had that turned out to be ...","quote":"For some people its the carpal tunnel feeling from GH peptides. For others its the flushing on PT-141","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":12029,"tokens_out":2744,"cost":0.02189625,"prev_hash":"genesis","hash":"37f21012e87ac5a8020cf1c976815f11ff4a1d3f558d8ec56c7a640e557815fb"}],"provenance":[{"ts":"2026-06-30T01:21:01.272Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Carpal Tunnel\nSlug: pt-141-carpal-tunnel\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Carpal tunnel syndrome\",\"condition_key\":\"carpal-tunnel\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Carpal tunnel syndrome\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Carpal tunnel syndrome** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have Carpal tunnel syndrome\",\"Why PT-141 might help you\",\"How th","response":"{\"slug\":\"pt-141-carpal-tunnel\",\"title\":\"PT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Review\",\"body\":\"## What's breaking down if you have Carpal tunnel syndrome\\n\\nCarpal tunnel syndrome involves compression of the median nerve as it passes through the narrow carpal tunnel at the wrist. This compression often stems from swelling in the surrounding tendons or tissues. Over time the pressure can lead to nerve irritation, reduced blood flow to the nerve, and changes in nerve conduction.\\n\\nIf the swelling persists, the protective myelin sheath around the nerve fibers can thin. This slows or blocks signals traveling to and from the fingers and hand. In longer cases some axons may degenerate, which means the nerve itself loses parts of its structure.\\n\\nThe condition sits at the intersection of mechanical pressure and biological repair. When tissue breakdown outpaces the body's ability to clear inflammation and rebuild nerve support, symptoms such as numbness, tingling, and weakness continue.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about carpal tunnel syndrome — what breaks down matters before any compound name.\\n2. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 acts on melanocortin receptors in the central nervous system. This pathway is best studied for sexual arousal. If carpal tunnel symptoms include a central nervous system component such as altered pain processing or reduced nerve signaling efficiency, the same receptors might intersect with repair signals in theory. No direct if-then chain from arousal to median-nerve regeneration has been mapped in published work.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- PT-141 → sexual / CNS arousal\\n\\nThe discussion stays limited to one compound because only PT-141","tokens_in":12029,"tokens_out":2744,"cost":0,"prev":"genesis","hash":"10c05de3848eeeb7be009b4d6e6f847d38699a22cd4f795abe6f846bfe0843b8"},{"ts":"2026-07-17T02:41:04.353Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-carpal-tunnel","response":"25 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"10c05de3848eeeb7be009b4d6e6f847d38699a22cd4f795abe6f846bfe0843b8","hash":"e6860be943e1a578f2943c0fde4a78716d519eb5548a98af00bc45d9bc43b3f0"}],"energy":{"passes":2,"tokens_in":12029,"tokens_out":2744,"tokens_total":14773,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e6860be943e1a578f2943c0fde4a78716d519eb5548a98af00bc45d9bc43b3f0"},"posted_at":"2026-06-29T21:32:51.525Z","created_at":"2026-06-29T21:32:51.525Z","updated_at":"2026-07-17T02:41:04.353Z","machine":{"shape":"article.machine/v1","slug":"pt-141-carpal-tunnel","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-carpal-tunnel","json":"https://miscsubjects.com/api/articles/pt-141-carpal-tunnel","bundle":"https://miscsubjects.com/api/articles/pt-141-carpal-tunnel/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-carpal-tunnel/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-carpal-tunnel","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-carpal-tunnel\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-carpal-tunnel\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-carpal-tunnel/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-carpal-tunnel\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-carpal-tunnel | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-carpal-tunnel","json":"/api/articles/pt-141-carpal-tunnel","markdown":"/api/articles/pt-141-carpal-tunnel/bundle?format=markdown","skill":"/api/articles/pt-141-carpal-tunnel/skill","topology":"/api/articles/pt-141-carpal-tunnel/topology","versions":"/api/articles/pt-141-carpal-tunnel/revisions","invocations":"/api/articles/pt-141-carpal-tunnel/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-carpal-tunnel","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"d9d639c3d71583cc512572a6233274e04b6d624ac2c29462fc9675f059ac8ac5"}}}